Frazier Healthcare Partners’s $617 Million Life Sciences Fund

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Frazier Healthcare Partners.

Frazier Healthcare Partners announced the closure of a $617 million fund, also known as Frazier Life Sciences X. The firm’s twelfth fund, the third dedicated life sciences fund, will continue its three-pronged strategy of investing in company creation, early-stage and late private/public opportunities. The fresh cash will be used to invest in therapeutics-focused companies developing and commercializing biopharmaceuticals.

The Gunderson Dettmer deal team was led by Stig Colberg and included Steve Franklin, Jaime Narayan (Picture), Sally Yi and Amanda Chan.

Involved fees earner: Amanda Chan – Gunderson Dettmer; Stig Colberg – Gunderson Dettmer; Steven Franklin – Gunderson Dettmer; Jaime Narayan – Gunderson Dettmer; Sally Yi – Gunderson Dettmer;

Law Firms: Gunderson Dettmer;

Clients: Frazier Healthcare Partners;

Author: Ambrogio Visconti